Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Journal of the American College of Cardiology
|
October 2, 2024
Risk of Ischemic Stroke After Patent Foramen Ovale Closure
Kasper Bonnesen, Kasper Korsholm, Asger Andersen, et al.
Thrombosis Research
|
February 21, 2022
Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolism
Kasper Bonnesen, Uffe Heide-Jørgensen, Lisbeth Wellejus Albertsen, et al.
BMJ Open
|
February 22, 2022
Type 2 diabetes and risk of diverticular disease: a Danish cohort study
Felix Wittström, Nils Skajaa, Kasper Bonnesen, et al.
Structural Heart : the Journal of the Heart Team
|
May 25, 2026
Workforce Attachment After Patent Foramen Ovale Closure
Kasper Bonnesen, Nils Skajaa, Kristina Laut, et al.
Drug Safety
|
May 2, 2023
Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study
Kasper Bonnesen, Lars Pedersen, Vera Ehrenstein, et al.
Diabetes, Obesity & Metabolism
|
June 3, 2026
Empagliflozin Versus Dapagliflozin and Urogenital Adverse Events in Type 2 Diabetes: A Target Trial Emulation
Christine Ljungberg, Kasper Bonnesen, Morten Schmidt, et al.
JAMA Internal Medicine
|
January 20, 2026
SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes
Simon K Jensen, Uffe Heide-Jørgensen, Ina T Andersen, et al.
The American Journal of Cardiology
|
May 18, 2023
Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism
Kasper Bonnesen, Frederikus A Klok, Mads J Andersen, et al.
Pharmacoepidemiology and Drug Safety
|
December 3, 2025
Cardiovascular Effectiveness of Semaglutide Versus Dulaglutide in Type 2 Diabetes
Kasper Bonnesen, Uffe Heide-Jørgensen, Diana H Christensen, et al.
Circulation
|
August 29, 2024
Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation
Kasper Bonnesen, Uffe Heide-Jørgensen, Diana H Christensen, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Journal of the American College of Cardiology
|
October 2, 2024
Risk of Ischemic Stroke After Patent Foramen Ovale Closure
Kasper Bonnesen, Kasper Korsholm, Asger Andersen, et al.
Thrombosis Research
|
February 21, 2022
Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolism
Kasper Bonnesen, Uffe Heide-Jørgensen, Lisbeth Wellejus Albertsen, et al.
BMJ Open
|
February 22, 2022
Type 2 diabetes and risk of diverticular disease: a Danish cohort study
Felix Wittström, Nils Skajaa, Kasper Bonnesen, et al.
Structural Heart : the Journal of the Heart Team
|
May 25, 2026
Workforce Attachment After Patent Foramen Ovale Closure
Kasper Bonnesen, Nils Skajaa, Kristina Laut, et al.
Drug Safety
|
May 2, 2023
Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study
Kasper Bonnesen, Lars Pedersen, Vera Ehrenstein, et al.
Diabetes, Obesity & Metabolism
|
June 3, 2026
Empagliflozin Versus Dapagliflozin and Urogenital Adverse Events in Type 2 Diabetes: A Target Trial Emulation
Christine Ljungberg, Kasper Bonnesen, Morten Schmidt, et al.
JAMA Internal Medicine
|
January 20, 2026
SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes
Simon K Jensen, Uffe Heide-Jørgensen, Ina T Andersen, et al.
The American Journal of Cardiology
|
May 18, 2023
Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism
Kasper Bonnesen, Frederikus A Klok, Mads J Andersen, et al.
Pharmacoepidemiology and Drug Safety
|
December 3, 2025
Cardiovascular Effectiveness of Semaglutide Versus Dulaglutide in Type 2 Diabetes
Kasper Bonnesen, Uffe Heide-Jørgensen, Diana H Christensen, et al.
Circulation
|
August 29, 2024
Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation
Kasper Bonnesen, Uffe Heide-Jørgensen, Diana H Christensen, et al.
Page
of 5